Bank Of America Corp Abb Vie Inc. Call Options Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

Call Options

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $49.2 Million - $59.9 Million	300,500 Added 72.94%	712,500 $141 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $50.4 Million - $58.9 Million	-325,800 Reduced 44.16%	412,000 $70.7 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $21.8 Million - $24.9 Million	-136,600 Reduced 15.62%	737,800 $134 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $15.9 Million - $17.9 Million	115,800 Added 15.26%	874,400 $136 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $67.2 Million - $83.6 Million	-507,200 Reduced 40.07%	758,600 $102 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $86.6 Million - $99.7 Million	598,900 Added 89.8%	1,265,800 $202 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $31 Million - $37.2 Million	224,100 Added 50.61%	666,900 $108 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $8.03 Million - $9.21 Million	-59,800 Reduced 11.9%	442,800 $59.4 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $5.26 Million - $6.68 Million	-38,200 Reduced 7.06%	502,600 $77 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $27.9 Million - $34.7 Million	-211,700 Reduced 28.13%	540,800 $87.7 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $46.7 Million - $59.1 Million	434,800 Added 136.86%	752,500 $102 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $33.8 Million - $38.3 Million	-317,400 Reduced 49.98%	317,700 $34.3 Million
Q2 2021 Sep 13, 2021	BUY	$105.21 - $117.21 $66.8 Million - $74.4 Million	635,100 New	635,100 $71.5 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account